on CureVac (NASDAQ:CVAC)
CureVac Announces Financial Results and Business Update for 2024
CureVac N.V., a global biotech company based in Germany and the US, plans to release its financial results for the fourth quarter and full-year 2024 on April 10, 2025. The company, renowned for its mRNA-based technologies, will also provide a business update on this date. A conference call and webcast will occur at 3 p.m. CET/9 a.m. EST to discuss these results. Interested parties can access the webcast via CureVac's website.
CureVac's advances in mRNA technology have positioned it as a pioneer in the field, contributing significantly to COVID-19 vaccine development. The company is now expanding the use of mRNA into new therapeutic areas, including personalized cancer vaccines and prophylactic treatments.
R. H.
Copyright © 2025 FinanzWire, all reproduction and representation rights reserved.
Disclaimer: although drawn from the best sources, the information and analyzes disseminated by FinanzWire are provided for informational purposes only and in no way constitute an incentive to take a position on the financial markets.
Click here to consult the press release on which this article is based
See all CureVac news